Literature DB >> 8421137

Subclinical celiac sprue. Increasing occurrence and clues to its diagnosis.

G R Corazza1, M Frisoni, E A Treggiari, R A Valentini, C Filipponi, U Volta, G Gasbarrini.   

Abstract

We have reviewed the clinical records of 226 consecutive adult patients with celiac sprue diagnosed in our department from 1972 to 1989. The study period has been divided into three subperiods of 6 years each (1972-1977, 1978-1983, 1984-1989). From the first to the third subperiod a significant increase in the number of new diagnoses and of the proportion of patients recognized by minor symptoms has been observed. These patients represent 50% of our series in the last 3 years of the study and 70% in 1989. Diagnosing subclinical forms of celiac sprue has significantly lowered the mean age at diagnosis and the female/male ratio. First-degree relatives of celiac patients; subjects who had a gluten-free diet for a period during childhood; patients with short stature, anemia, or amenorrhea of no obvious cause; or patients with unexplained immunological abnormalities are the groups in which most patients with subclinical celiac sprue have been found and in which potential patients should be sought. Helpful diagnostic tools include antigliadin antibody testing and the observation of absent or reduced Kerckring folds in the descending duodenum in the course of upper gastrointestinal endoscopy.

Entities:  

Mesh:

Year:  1993        PMID: 8421137

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  22 in total

1.  Increased risk of surgery in undiagnosed celiac disease.

Authors:  C Ciacci; R Cavallaro; R Romano; D S Galletta; F Labanca; M Marino; M Donisi; G Mazzacca
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

2.  Estimating the incidence of coeliac disease with capture-recapture methods within four geographic areas in Italy.

Authors:  G Corrao; P Usai; G Galatola; N Ansaldi; A Meini; M A Pelli; G Castellucci; G R Corazza
Journal:  J Epidemiol Community Health       Date:  1996-06       Impact factor: 3.710

Review 3.  Urban legends: recurrent aphthous stomatitis.

Authors:  L Baccaglini; R V Lalla; A J Bruce; J C Sartori-Valinotti; M C Latortue; M Carrozzo; R S Rogers
Journal:  Oral Dis       Date:  2011-08-04       Impact factor: 3.511

4.  Osteopenia in adult coeliac disease.

Authors:  M Di Stefano; R Jorizzo; G R Corazza
Journal:  Gut       Date:  1996-09       Impact factor: 23.059

5.  The Oslo definitions for coeliac disease and related terms.

Authors:  Jonas F Ludvigsson; Daniel A Leffler; Julio C Bai; Federico Biagi; Alessio Fasano; Peter H R Green; Marios Hadjivassiliou; Katri Kaukinen; Ciaran P Kelly; Jonathan N Leonard; Knut Erik Aslaksen Lundin; Joseph A Murray; David S Sanders; Marjorie M Walker; Fabiana Zingone; Carolina Ciacci
Journal:  Gut       Date:  2012-02-16       Impact factor: 23.059

6.  Celiac disease and pediatric type 1 diabetes: diagnostic and treatment dilemmas.

Authors:  Shama Sud; Margaret Marcon; Esther Assor; Mark R Palmert; Denis Daneman; Farid H Mahmud
Journal:  Int J Pediatr Endocrinol       Date:  2010-06-23

7.  Serological screening of coeliac disease: choosing the optimal procedure according to various prevalence values.

Authors:  G Corrao; G R Corazza; M L Andreani; P Torchio; R A Valentini; G Galatola; D Quaglino; G Gasbarrini; F di Orio
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

8.  Psychological dimensions of celiac disease: toward an integrated approach.

Authors:  Carolina Ciacci; Alessandro Iavarone; Monica Siniscalchi; Rita Romano; Antonio De Rosa
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

9.  Iron-deficiency anemia as the sole manifestation of celiac disease.

Authors:  U Schmitz; Y Ko; S Seewald; R Düsing; H Vetter
Journal:  Clin Investig       Date:  1994-07

10.  Osteoporosis in treated adult coeliac disease.

Authors:  X A McFarlane; A K Bhalla; D E Reeves; L M Morgan; D A Robertson
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.